2024-01-29T03:01:37-07:00 2022-12-31 262176601 EASY OFFICE DBA JITASA 1120 S RACKHAM WAY SUITE 300 MERIDIAN ID 83642 990 2022-01-01 814011501 PATIENTS FOR AFFORDABLE DRUGS PATI 2027347555 1155 15TH ST N W SUITE 500 WASHINGTON DC 20005 DAVID MITCHELL PRESIDENT/FOUNDER 2027347555 2024-01-29 1 1 JEREMY CORK P01544850 2082874777 2024-01-29 1 11 1 AAL2 X 2022 2023-04-26 12:10:37Z X DAVID MITCHELL 1155 15TH ST N W SUITE 500 WASHINGTON DC 20005 2028313 0 X patientsforaffordabledrugs.org X 2016 MD THE PURPOSE OF PATIENTS FOR AFFORDABLE DRUGS IS TO PROMOTE HEALTH BY RAISING THE VOICES OF PATIENTS AND THEIR FAMILIES ON THE CAUSES OF HIGH DRUG PRICES AND TO HELP EDUCATE THEM ABOUT HOW THEY CAN BE A PART OF THE DISCUSSION AND WORK TO MAKE REFORMS TO THE US SYSTEM OF DRUG PRICING IN THE PRIVATE AND PUBLIC SECTORS. 4 4 13 4 0 0 578328 1453409 25000 0 95 54 0 574850 603423 2028313 0 0 0 0 738598 1276476 0 0 0 403827 531896 1142425 1808372 -539002 219941 344432 525316 58323 61303 286109 464013 THE PURPOSE OF PATIENTS FOR AFFORDABLE DRUGS IS TO PROMOTE HEALTH BY RAISING THE VOICES OF PATIENTS AND THEIR FAMILIES ON THE CAUSES OF HIGH DRUG PRICES AND TO HELP EDUCATE THEM ABOUT HOW THEY CAN BE A PART OF THE DISCUSSION AND WORK TO MAKE REFORMS TO THE US SYSTEM OF DRUG PRICING IN THE PRIVATE AND PUBLIC SECTORS. 0 0 1684737 0 0 GENERAL PROGRAM: THE GENERAL PROGRAM CONSISTS OF BUILDING A PATIENT-CENTERED COALITION THAT IS FINANCIALLY INDEPENDENT FROM ANY PHARMACEUTICAL INDUSTRY SUPPORT WITH A MISSION TO EDUCATE THE PUBLIC, PATIENTS, AND KEY STAKEHOLDERS ABOUT BOTH THE REAL-LIFE CHALLENGES THAT PATIENTS FACE UNDER THE CURRENT DRUG DEVELOPMENT AND PRICING FRAMEWORK. 0 0 0 1684737 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 5 0 1 13 1 0 0 0 0 0 0 0 0 0 0 0 0 X 4 4 0 0 0 0 0 0 0 1 1 0 0 1 0 0 0 1 1 0 X X EASY OFFICE DBA JITASA 2082874777 1120 S RACKHAM WAY SUITE 300 MERIDIAN ID 83642 WENDY CHEW CHIEF OPERATING OFFICER 40 40 X 166097 0 20585 LUCY WESTERFIELD DEPUTY EXECUTIVE DIRECTOR 40 X 167798 0 6826 SARAH KAMINER BOURLAND LEGISLATIVE DIRECTOR 40 X 153533 0 5039 MERITH BASEY EXECUTIVE DIRECTOR 40 40 X 72934 0 1838 DAVID MITCHELL PRESIDENT/FOUNDER 40 20 X X 0 0 0 CAL LAROCHE TREASURER 1 X X 0 0 0 CHARLES HURLEY BOARD MEMBER 1 X 0 0 0 TOMI FADEYI-JONES BOARD MEMBER 1 X 0 0 0 560362 0 34288 3 0 1 0 0 0 0 0 0 0 1453409 0 1453409 0 54 0 0 54 0 0 0 0 0 0 0 0 0 0 0 0 0 REVENUE FROM REIMBURSEMENT (RELATED ORGANIZATION) 900099 574850 574850 0 0 0 0 0 0 574850 2028313 574850 0 54 599034 567749 31285 526854 526854 29757 29757 36480 31569 4911 84351 84351 1084 1084 9204 9204 67152 59697 7455 45529 40917 4612 131967 131506 461 55742 5920 49822 3547 1417 2130 5845 5159 686 7430 7430 PROGRAM EXPENSES - MEDIA 103208 103208 0 0 RECRUITING 101188 88119 13069 0 1808372 1684737 123635 0 48812 339736 61596 53717 123212 85279 43066 12021 8503 6813 3518 103999 344432 525316 58323 61303 58323 61303 X 286109 464013 0 0 286109 464013 344432 525316 219941 0 0 0 -42037 0 X 0 1 X 1 0 X 556278 1648391 874759 578328 1453409 5111165 556278 1648391 874759 578328 1453409 5111165 4391526 719639 3528 5803 1629 95 54 11109 574850 574850 5697124 25000 0.12632 0.10269 X PATIENTS FOR AFFORDABLE DRUGS (P4AD) MEETS THE FACTS AND CIRCUMSTANCES TEST IN 26 CFR § 1.170A-9(F)(3) AS A PUBLICLY SUPPORTED ORGANIZATION. THE ORGANIZATION HAS CREATED A ROBUST COMMUNITY OF PATIENTS OVER ITS FIRST FIVE YEARS IN OPERATION AND IS DEMONSTRABLY A PUBLIC CHARITY THAT IS SERVING PEOPLE IN NEED, AND ESPECIALLY LOWER INCOME AMERICANS WHO CANNOT AFFORD THEIR PRESCRIPTION DRUGS. P4AD IS THE ONLY FULLY INDEPENDENT NATIONAL PATIENT ORGANIZATION FOCUSED EXCLUSIVELY ON PROMOTING POLICIES THAT WILL LOWER THE PRICES OF PRESCRIPTION DRUGS. WE DO NOT ACCEPT FUNDING FROM ANY ORGANIZATIONS THAT PROFIT FROM THE DEVELOPMENT OR DISTRIBUTION OF PRESCRIPTION DRUGS. IN THE FIRST FIVE YEARS OF OUR EXISTENCE, P4AD STRATEGICALLY CHOSE TO AVOID ASKING PATIENTS FOR FINANCIAL CONTRIBUTIONS BECAUSE WE KNEW MANY WERE ALREADY STRUGGLING TO PAY HIGH PRICES FOR THEIR MEDICINES - THAT'S WHY THEY ENGAGED WITH US. ONE OUT OF FOUR AMERICANS REPORT IT IS VERY DIFFICULT FOR THEM TO AFFORD THEIR PRESCRIPTION DRUGS (HTTPS://WWW.KFF.ORG/HEALTH-COSTS/POLL-FINDING/PUBLIC-OPINION-ON-PRESCRIPTION-DRUGS-AND-THEIR-PRICES/). ALMOST ONE IN THREE SAY THEY HAVE NOT TAKEN PRESCRIPTION MEDICATIONS AS DIRECTED BECAUSE OF COSTS. HIGH DRUG PRICES DISPROPORTIONATELY IMPACT BLACK AND BROWN PEOPLE AND CONTRIBUTE TO THE PERPETUATION OF SYSTEMIC RACISM THROUGH WORSE HEALTH OUTCOMES. BLACK AMERICANS ARE ALMOST TWICE AS LIKELY TO BE UNINSURED AND HAVE LOWER INCOMES THAN WHITE AMERICANS. WE SPOTLIGHTED AND DOCUMENTED THIS ISSUE IN 2020 IN A BLOG AUTHORED BY OUR BOARD OF DIRECTORS. PATIENTS NEEDED A PLATFORM TO AMPLIFY THEIR STORIES TO POLICYMAKERS AND ELECTED OFFICIALS, AND WE BELIEVED IT WAS INAPPROPRIATE TO ASK THE VERY PEOPLE WHO ARE UNABLE TO AFFORD THE LIFESAVING MEDICATIONS THEY NEED TO SEND US MONEY. SEE 26 CFR § 1.170A-9(F)(3)(III)(B) ("IN DETERMINING WHAT IS A "REPRESENTATIVE NUMBER OF PERSONS," CONSIDERATION WILL BE GIVEN TO THE TYPE OF ORGANIZATION INVOLVED, THE LENGTH OF TIME IT HAS BEEN IN EXISTENCE, AND WHETHER IT LIMITS ITS ACTIVITIES TO A PARTICULAR COMMUNITY OR REGION OR TO A SPECIAL FIELD WHICH CAN BE EXPECTED TO APPEAL TO A LIMITED NUMBER OF PERSONS"). INSTEAD OF SEEKING FUNDING FROM THOSE WHO FACE DISPROPORTIONATE FINANCIAL HARM FROM HIGH DRUG PRICES, WE SOUGHT FUNDING FROM OTHER SOURCES AND ASKED PATIENTS FOR THEIR PERSONAL STORIES AND EMAIL ADDRESSES WHICH FORM THE BASIS OF - THE CURRENCY OF - ALL OUR ORGANIZING AND COMMUNICATIONS WORK. SEE 26 CFR § 1.170A-9(F)(3)(II) ("CONSIDERATION WILL ALSO BE GIVEN TO THE FACT THAT AN ORGANIZATION, IN ITS EARLY YEARS OF EXISTENCE, MAY LIMIT THE SCOPE OF ITS SOLICITATION TO PERSONS DEEMED MOST LIKELY TO PROVIDE SEED MONEY IN AN AMOUNT SUFFICIENT TO ENABLE IT TO COMMENCE ITS CHARITABLE ACTIVITIES AND EXPAND ITS SOLICITATION PROGRAM"). THE CORE OF OUR WORK IS TO RAISE UP PATIENT STORIES, AMPLIFY THEIR VOICES AND ENGAGE AND TRAIN PEOPLE TO COMMUNICATE ON THEIR OWN BEHALF. SINCE FEBRUARY, 2017 WHEN WE PUBLICLY LAUNCHED P4AD, WE HAVE COLLECTED MORE THAN 32,000 PATIENT STORIES WHICH ARE DISPLAYED ON OUR WEBSITE. PATIENTS FOR AFFORDABLE DRUGS, MAP OF STORIES COLLECTED, AT HTTPS://MAP.PATIENTSFORAFFORDABLEDRUGS.ORG/ (LAST ACCESSED OCTOBER 20, 2022). OUR EMAIL COMMUNITY HAS GROWN FROM ZERO TO MORE THAN 420,000 NOW, DEMONSTRATING BROAD SUPPORT AND ENGAGEMENT WITH THE PEOPLE WE ARE WORKING TO SERVE. OUR ACTIVIST SMS TEXT PROGRAM ENGAGES MORE THAN 58,000 AMERICANS - A SIGNIFICANT PROPORTION OF WHOM READ AND TAKE ACTION WEEKLY PROMPTED BY OUR COMMUNICATIONS. WE NOW HAVE OVER 300 TRAINED ADVOCATES ALL ACROSS THE COUNTRY WHO GIVE OF THEIR TIME AND ENERGY IN SUPPORT OF P4AD. OUR PATIENT ADVOCATES WRITE BLOGS, LETTERS TO THE EDITOR, SPEAK TO THE NEWS MEDIA, AND VISIT WITH THEIR ELECTED OFFICIALS. THEY MAKE THEIR STORIES KNOWN AND RAISE THEIR VOICES FOR CHANGE. LOOKING FORWARD, A NEW EXECUTIVE DIRECTOR WHO JOINED THE TEAM IN SEPTEMBER 2022, WILL LEAD A STEPPED UP FUNDRAISING AND DEVELOPMENT STRATEGY COMMENCING AT THE END OF 2022, TO BROADEN OUR BASE OF FINANCIAL SUPPORT. NOW THAT WE ARE ESTABLISHED AND CAN POINT TO CONCRETE ACHIEVEMENTS ON BEHALF OF PATIENTS, WE HAVE BEGUN TO ASK PATIENTS AND POTENTIAL ALLIES FOR SMALL DONATIONS, AND WE ARE INCREASING THE FUNDING FROM THOSE SOURCES, IN ADDITION TO THEIR STORIES, EMAILS AND ENGAGEMENT OF THEIR TIME AND EFFORT IN SUPPORT OF OUR WORK. WE ARE ALSO SEEKING TO INCREASE GRANTS FROM PUBLIC CHARITIES AS WELL, AND HAVE IMPROVED THE PUBLIC SUPPORT PERCENTAGE. 26 CFR § 1.170A-9(F)(3)(II). REGARDLESS, IF INDIVIDUALS ARE WILLING TO DONATE THEIR TIME, VOICE AND STORIES IN LARGE ENOUGH NUMBERS IN SUPPORT OF A CAUSE IN WHICH THEY BELIEVE, THOSE EXPRESSIONS AND ACTIONS ESTABLISH PUBLIC SUPPORT. P4AD CLEARLY PROVIDES THESE SERVICES TO THE BENEFIT OF THE GENERAL PUBLIC ON A CONTINUOUS BASIS AND SUPPORTS GENERAL REFORMS THAT HAVE THE BACKING OF 80 PERCENT OF AMERICANS (HTTPS://WWW.KFF.ORG/HEALTH-COSTS/POLL-FINDING/KFF-HEALTH-TRACKING-POLL-MAY-2021/). IT IS TO THE BENEFIT OF THE GENERAL PUBLIC THAT THE COSTS OF PRESCRIPTION DRUGS BE LOWER, AND P4AD CENTERS ITS PROGRAM AROUND SERVING AND COLLECTING STORIES FROM THE GENERAL PUBLIC THAT IT SERVES. 26 CFR § 1.170A-9(F)(3)(III)(D). FOR THESE REASONS, WE BELIEVE THAT THE FACTS AND CIRCUMSTANCES CLEARLY INDICATE THAT P4AD IS A PUBLICLY SUPPORTED ORGANIZATION. Schedule A, Part II, Line 10 REVENUE FROM REIMBURSEMENT (RELATED ORGANIZATION). RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 0 0 0 0 0 0 0 0 0 12021 8503 3518 0 0 0 0 3518 2028313 0 0 0 0 0 2028313 0 0 0 2028313 1808372 0 0 0 0 0 1808372 0 0 0 1808372 0 0 0 0 0 0 0 0 0 WENDY CHEW CHIEF OPERATING OFFICER 153597 0 12500 0 2750 0 0 0 17835 0 186682 0 0 0 LUCY WESTERFIELD DEPUTY EXECUTIVE DIRECTOR 155298 0 12500 0 2666 0 0 0 4160 0 174624 0 0 0 SARAH KAMINER BOURLAND LEGISLATIVE DIRECTOR 141033 0 12500 0 0 0 0 0 5039 0 158572 0 0 0 Form 990, Part VI, Section B, Line 11b THE FORM 990 DRAFT IS SHARED WITH THE BOARD MEMBERS VIA EMAIL. Form 990, Part VI, Section B, Line 15 THE EXECUTIVE DIRECTOR'S COMPENSATION WAS REVIEWED AND APPROVED BY THE FOUNDER, DAVID MITCHELL. ALL STAFF THAT REPORTS TO THE EXECUTIVE DIRECTOR HAS THEIR COMPENSATION REVIEWED AND APPROVED BY THE EXECUTIVE DIRECTOR WHO CONSULTED WITH THE FOUNDER FOR COMPENSATION DECISIONS. Form 990, Part VI, Section C, Line 19 THE FORM 990 IS MADE AVAILABLE TO THE PUBLIC VIA GUIDESTAR.ORG AND IRS.GOV WEBSITES. GOVERNING DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON REASONABLE REQUEST. PATIENTS FOR AFFORDABLE DRUGS NOW 1155 15TH ST N W SUITE 500 WASHINGTON DC 20005 823044855 MOBILIZE PATIENTS TO SUPPORT LEGISLATION TO LOWER DRUG PRICES. DC 501(c)(4) N/A N/A 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 PATIENTS FOR AFFORDABLE DRUGS NOW o 535385 ACTUAL COST PATIENTS FOR AFFORDABLE DRUGS NOW n 39465 ACTUAL COST